GB0401862D0 - Use of combinations of pyrazolo[1, 5-B]pyridazine derivatives and pyrimidine derivatives with SSRI inhibitors for the treatment of depressive disorders
- Google Patents
Use of combinations of pyrazolo[1, 5-B]pyridazine derivatives and pyrimidine derivatives with SSRI inhibitors for the treatment of depressive disorders
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0401862A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group LtdfiledCriticalGlaxo Group Ltd
Priority to GB0401862ApriorityCriticalpatent/GB0401862D0/en
Publication of GB0401862D0publicationCriticalpatent/GB0401862D0/en
Priority to EP04797973Aprioritypatent/EP1687000A2/en
Priority to PCT/EP2004/013070prioritypatent/WO2005048999A2/en
Priority to US10/595,800prioritypatent/US20070270428A1/en
Priority to JP2006540317Aprioritypatent/JP2007511569A/en
GB0401862A2003-11-192004-01-28Use of combinations of pyrazolo[1, 5-B]pyridazine derivatives and pyrimidine derivatives with SSRI inhibitors for the treatment of depressive disorders
CeasedGB0401862D0
(en)
Use of combinations of pyrazolo[1, 5-B]pyridazine derivatives and pyrimidine derivatives with SSRI inhibitors for the treatment of depressive disorders
Use of combinations of pyrazolo[1, 5-B]pyridazine derivatives and pyrimidine derivatives with SSRI inhibitors for the treatment of depressive disorders
Use of combinations of pyrazolo[1, 5-B]pyridazine derivatives and pyrimidine derivatives with SSRI inhibitors for the treatment of depressive disorders
Novel imidazo [4,5-b]pyridine derivatives as inhibitors of glycogen synthase kinase 3 for use in the treatment of dementia and neurodegenerative disorders
4, 5-dihydro- [1, 2, 4] triazolo [4,3-f] pteridines as protein kinase plk1 inhibitors for the treatment of proliferative disorders plk1 45--[124][43- f]
Use of combinations of pyrazolo[1, 5-B]pyridazine derivatives and pyrimidine derivatives with SSRI inhibitors for the treatment of depressive disorders